OpenURL Connection Search

Select item for more details and to access through your institution.

IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction.
Published in:
Frontiers in Immunology, 2018, p. 1, doi. 10.3389/fimmu.2018.02035
By:
- Orrem, Hilde L.;
- Nilsson, Per H.;
- Pischke, Søren E.;
- Kleveland, Ola;
- Yndestad, Arne;
- Ekholt, Karin;
- Damås, Jan K.;
- Espevik, Terje;
- Bendz, Bjørn;
- Halvorsen, Bente;
- Gregersen, Ida;
- Wiseth, Rune;
- Andersen, Geir Ø.;
- Ueland, Thor;
- Gullestad, Lars;
- Aukrust, Pål;
- Barratt-Due, Andreas;
- Mollnes, Tom E.
Publication type:
Article
Novel Insights Into the Effects of Interleukin 6 Antagonism in Non-ST-Segment-Elevation Myocardial Infarction Employing the SOMAscan Proteomics Platform.
Published in:
2020
By:
- George, Marc J.;
- Kleveland, Ola;
- Garcia-Hernandez, Jorge;
- Palmen, Jutta;
- Lovering, Ruth;
- Wiseth, Rune;
- Aukrust, Pål;
- Engmann, Jorgen;
- Damås, Jan Kristian;
- Hingorani, Aroon D.;
- Gullestad, Lars;
- Casas, Juan P.;
- Ueland, Thor
Publication type:
journal article
Hypergastrinemia as a Cause of Chromogranin A Increase in Blood in Patients Suspected to Have Neuroendocrine Tumor.
Published in:
Digestion, 2001, v. 64, n. 2, p. 71, doi. 10.1159/000048842
By:
- Kleveland, Ola;
- Syversen, Unni;
- Slørdahl, Kari;
- Waldum, Helge L.
Publication type:
Article
Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-STelevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial.
Published in:
European Heart Journal, 2016, v. 37, n. 30, p. 2406, doi. 10.1093/eurheartj/ehw171
By:
- Kleveland, Ola;
- Kunszt, Gabor;
- Bratlie, Marte;
- Ueland, Thor;
- Broch, Kaspar;
- Holte, Espen;
- Michelsen, Annika E.;
- Bendz, Bjørn;
- Amundsen, Brage H.;
- Espevik, Terje;
- Aakhus, Svend;
- Damås, Jan Kristian;
- Aukrust, Pål;
- Wiseth, Rune;
- Gullestad, Lars
Publication type:
Article
Circular RNA Profile in Atherosclerotic Disease: Regulation during ST-Elevated Myocardial Infarction.
Published in:
International Journal of Molecular Sciences, 2024, v. 25, n. 16, p. 9014, doi. 10.3390/ijms25169014
By:
- Holme, Fredric A.;
- Huse, Camilla;
- Kong, Xiang Yi;
- Broch, Kaspar;
- Gullestad, Lars;
- Anstensrud, Anne Kristine;
- Andersen, Geir Ø.;
- Amundsen, Brage H.;
- Kleveland, Ola;
- Quiles-Jimenez, Ana;
- Holm, Sverre;
- Aukrust, Pål;
- Alseth, Ingrun;
- Halvorsen, Bente;
- Dahl, Tuva B.
Publication type:
Article

Found: 5

IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction.

Novel Insights Into the Effects of Interleukin 6 Antagonism in Non-ST-Segment-Elevation Myocardial Infarction Employing the SOMAscan Proteomics Platform.

Hypergastrinemia as a Cause of Chromogranin A Increase in Blood in Patients Suspected to Have Neuroendocrine Tumor.

Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-STelevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial.

Circular RNA Profile in Atherosclerotic Disease: Regulation during ST-Elevated Myocardial Infarction.